Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Gabriela, Plesa"'
Autor:
Julie K. Jadlowsky, Rachel Leskowitz, Stephen McKenna, Jayashree Karar, Yujie Ma, Anlan Dai, Gabriela Plesa, Fang Chen, Kathleen Alexander, Jennifer Petrella, Nan Gong, Wei-Ting Hwang, Olivia Farrelly, Julie Barber-Rotenberg, Shannon Christensen, Vanessa E. Gonzalez, Anne Chew, Joseph A. Fraietta, Carl H. June
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 1, Pp 101186- (2024)
The use of lentiviral vectors in cell and gene therapy is steadily increasing, both in commercial and investigational therapies. Although existing data increasingly support the usefulness and safety of clinical-grade lentiviral vectors used in cell m
Externí odkaz:
https://doaj.org/article/7bc0c17d5d0e4617bc7ee7d437b08ef4
Autor:
Carl H June, Joseph A Fraietta, Gabriela Plesa, Amy Marshall, Mark H O’Hara, Janos L Tanyi, Elizabeth Hexner, Julie Jadlowsky, Matthew Ferrara, Olivia Farrelly, Adam Runkle, Anne Chew, Emily Dowd, Vanessa Gonzalez, Neil C Sheppard
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/1487bb6e25384ec2b8e39e6e613b67d7
Autor:
January Salas-Mckee, Weimin Kong, Whitney L. Gladney, Julie K. Jadlowsky, Gabriela Plesa, Megan M. Davis, Joseph A. Fraietta
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 5, Pp 1126-1132 (2019)
The advent of engineered T cells as a form of immunotherapy marks the beginning of a new era in medicine, providing a transformative way to combat complex diseases such as cancer. Following FDA approval of CAR T cells directed against the CD19 protei
Externí odkaz:
https://doaj.org/article/41779d55186148e384de8c0f5be181d0
Autor:
Payal D. Shah, Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter, Paul Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E. John Wherry, Gerald P. Linette, Andrea Brennan, Vanessa Gonzalez, Irina Kulikovskaya, Simon F. Lacey, Gabriela Plesa, Carl H. June, Robert H. Vonderheide, Tara C. Mitchell
Publikováno v:
Cancer Research Communications. 3:821-829
Purpose: Treatments are limited for metastatic melanoma and metastatic triple-negative breast cancer (mTNBC). This pilot phase I trial (NCT03060356) examined the safety and feasibility of intravenous RNA-electroporated chimeric antigen receptor (CAR)
Autor:
Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya, Wei-Ting Hwang, Dan T. Vogl, Adam J. Waxman, Simon F. Lacey, Vanessa E. Gonzalez, Joseph A. Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L. Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Don L. Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V. Wilson, Fei Miao, Eric Lancaster, Beatriz M. Carreno, Gerald P. Linette, Elizabeth O. Hexner, Regina M. Young, Dexiu Bu, Keith G. Mansfield, Jennifer L. Brogdon, Carl H. June, Michael C. Milone, Edward A. Stadtmauer
Publikováno v:
Blood Cancer Discovery. 4:118-133
We conducted a phase I clinical trial of anti-BCMA chimeric antigen receptor T cells (CART-BCMA) with or without anti-CD19 CAR T cells (huCART19) in multiple myeloma (MM) patients responding to third- or later-line therapy (phase A, N = 10) or high-r
Autor:
Tara C. Mitchell, Robert H. Vonderheide, Carl H. June, Gabriela Plesa, Simon F. Lacey, Irina Kulikovskaya, Vanessa Gonzalez, Andrea Brennan, Gerald P. Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K. Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D. Shah
Study procedures. Participant study procedures including cell collection/manufacturing timeline as well as infusion schedule from eligibility confirmation onward.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e40732ed1e1a9fe11f9fc7a214caad
https://doi.org/10.1158/2767-9764.22787708.v1
https://doi.org/10.1158/2767-9764.22787708.v1
Autor:
Tara C. Mitchell, Robert H. Vonderheide, Carl H. June, Gabriela Plesa, Simon F. Lacey, Irina Kulikovskaya, Vanessa Gonzalez, Andrea Brennan, Gerald P. Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K. Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D. Shah
Purpose:Treatments are limited for metastatic melanoma and metastatic triple-negative breast cancer (mTNBC). This pilot phase I trial (NCT03060356) examined the safety and feasibility of intravenous RNA-electroporated chimeric antigen receptor (CAR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7637614404a385b771276bf3e332121
https://doi.org/10.1158/2767-9764.c.6547846
https://doi.org/10.1158/2767-9764.c.6547846
Autor:
Tara C. Mitchell, Robert H. Vonderheide, Carl H. June, Gabriela Plesa, Simon F. Lacey, Irina Kulikovskaya, Vanessa Gonzalez, Andrea Brennan, Gerald P. Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K. Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D. Shah
mRNA signals corresponding to CAR T cells in peripheral blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54192d6fb8fae12a3ddc28ee4aff8747
https://doi.org/10.1158/2767-9764.22787684.v1
https://doi.org/10.1158/2767-9764.22787684.v1
Autor:
Tara C. Mitchell, Robert H. Vonderheide, Carl H. June, Gabriela Plesa, Simon F. Lacey, Irina Kulikovskaya, Vanessa Gonzalez, Andrea Brennan, Gerald P. Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K. Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D. Shah
Supplementary Figure 1.: Representative immunohistochemical staining for Subject 74 with metastatic melanoma; lymph node biopsy. Panel A: pS6 staining prior to infusion; Panel B: pS6 staining at post-infusion biopsy; Panel C: Ki-67 staining prior to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa5cb6c559cc5419f376cd8cfbce516
https://doi.org/10.1158/2767-9764.22787702
https://doi.org/10.1158/2767-9764.22787702
Autor:
Tara C. Mitchell, Robert H. Vonderheide, Carl H. June, Gabriela Plesa, Simon F. Lacey, Irina Kulikovskaya, Vanessa Gonzalez, Andrea Brennan, Gerald P. Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K. Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D. Shah
Patient population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4077fdb1b2cdd2218fd9e984a2fcdb
https://doi.org/10.1158/2767-9764.22787696.v1
https://doi.org/10.1158/2767-9764.22787696.v1